Endo International Ordinary Shares reported $297.12M in Cost of Sales for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cost Of Sales Change
Abbvie ABBV:US $ 4341M 157M
Adamas Pharmaceuticals ADMS:US 576K 49K
Aerie Pharmaceuticals AERI:US $ 7.9M 1.72M
Amarin AMRN:US $ 30.21M 1.94M
Ani Pharmaceuticals ANIP:US $ 24.41M 2.1M
Biodelivery Sciences International BDSI:US $ 6.36M 2.08M
Bristol Myers Squibb BMY:US $ 2291M 160M
Coherus Biosciences CHRS:US $ 21.28M 4.58M
Eli Lilly And LLY:US $ 1430.8M 522.4M
Endo International Ordinary Shares ENDP:US $ 297.12M 16.31M
Flexion Therapeutics FLXN:US $ 3.73M 1.25M
Heron Therapeutics HRTX:US $ 11.35M 3.17M
Hikma Pharmaceutical HIK:LN 600M 2M
Horizon Pharma HZNP:US $ 251.64M 50.64M
JAZZ PHA JAZZ:US $ 145.22M 26.03M
Lannett LCI:US $ 85M 1.65M
Ligand Pharmaceuticals LGND:US $ 11.45M 19.15M
Merk MRK:US $ 3056M 14M
Novartis NOVN:VX SF 3848M 94M
Pacira Pharmaceuticals PCRX:US $ 34.65M 0.6M
Patterson Companies PDCO:US $ 1322.73M 14.35M
Perrigo Ordinary Shares PRGO:US $ 706.3M 74.2M
Pfizer PFE:US $ 9931M 2939M
Phibro Animal Health PAHC:US $ 149.99M 0.46M
Revance Therapeutics RVNC:US $ 5.89M 460K
Supernus Pharmaceuticals SUPN:US $ 18.08M 6.94M
Takeda 4502:JP Y 275797M 34533M
Teva Pharmaceutical TEVA:IT 1.99B 2M
Xeris Pharmaceuticals Inc XERS:US $ 3.22M 163K
Zoetis ZTS:US $ 582M 18M